These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17396051)

  • 1. Gender differences of enzymatic activity and distribution of 17beta-hydroxysteroid dehydrogenase in human skin in vitro.
    Hikima T; Maibach HI
    Skin Pharmacol Physiol; 2007; 20(4):168-74. PubMed ID: 17396051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
    Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
    Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
    Laplante Y; Rancourt C; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17Beta-hydroxysteroid dehydrogenases in human bone cells.
    Dong Y; Qiu QQ; Debear J; Lathrop WF; Bertolini DR; Tamburini PP
    J Bone Miner Res; 1998 Oct; 13(10):1539-46. PubMed ID: 9783542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
    Fournier MA; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 17beta-hydroxysteroid dehydrogenase type 4 in human ovarian surface epithelial cells.
    Nagayoshi Y; Ohba T; Yamamoto H; Miyahara Y; Tashiro H; Katabuchi H; Okamura H
    Mol Hum Reprod; 2005 Sep; 11(9):615-21. PubMed ID: 16219629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.
    Steckelbroeck S; Watzka M; Reissinger A; Wegener-Toper P; Bidlingmaier F; Bliesener N; Hans VH; Clusmann H; Ludwig M; Siekmann L; Klingmüller D
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):79-92. PubMed ID: 12943747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
    Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH.
    Jin JZ; Lin SX
    Biochem Biophys Res Commun; 1999 Jun; 259(2):489-93. PubMed ID: 10362535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
    Brooks JD; Thompson LU
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracrine control of estrogen action in human gestational tissues at parturition.
    Madsen G; Zakar T; Manuelpillai U; Wallace E; Kwek K; Yeo GS; Smith R; Mesiano S
    J Soc Gynecol Investig; 2004 May; 11(4):213-9. PubMed ID: 15120694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 17β-hydroxysteroid dehydrogenase and regulators involved in estrogen degradation in Pseudomonas putida SJTE-1.
    Wang P; Zheng D; Peng W; Wang Y; Wang X; Xiong W; Liang R
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2413-2425. PubMed ID: 30623203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.
    Ito K; Utsunomiya H; Suzuki T; Saitou S; Akahira J; Okamura K; Yaegashi N; Sasano H
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):136-40. PubMed ID: 16406263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of estrogen inactivation in colonic cancer.
    English MA; Kane KF; Cruickshank N; Langman MJ; Stewart PM; Hewison M
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2080-5. PubMed ID: 10372714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
    Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
    Bydal P; Auger S; Poirier D
    Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Couture P; Thériault C; Simard J; Labrie F
    Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.